Latest Sydney News

Page 3 of 91
Nexalis Therapeutics ended September with $371,000 in cash, equivalent to just 0.9 quarters of funding at its recent operating burn. The company has settled its dispute with Linlithgow Family Office, but its clinical programs remain paused while it pursues R&D tax funding and a new capital raise.
Ada Torres
Ada Torres
30 Oct 2026
Australian Rare Earths has produced its first Mixed Rare Earth Hydroxide at the Koppamurra pilot plant while extending an interpreted carbonatite system at Overland by roughly 5km. The operating progress comes with two important qualifiers: Koppamurra still needs further product refinement and Overland assays remain pending.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Doctor Care Anywhere’s Q3 revenue rose 16% to £11.3 million as its weight-management business delivered its first full quarter, lifting subscription revenue to 19% of the total. The unaudited update also shows modest consultation growth, higher cash and three new distribution partnerships.
Ada Torres
Ada Torres
30 Oct 2026
Battery Age Minerals advanced its Bleiberg germanium permits and expanded Falcon Lake to about 60 km², but its cash position now covers an estimated 1.34 quarters of funding. Initial Apex fieldwork also failed to confirm the remote-sensing anomalies that had defined the Utah targets.
Victor Sage
Victor Sage
30 Oct 2026
Hallenstein Glasson Holdings delivered a sharply stronger FY2026, with sales up 19.6% to NZ$563.0 million and net profit after tax rising 49.9% to NZ$59.2 million. The retailer enters FY2027 with strong early sales momentum, although management warns the opening 18.4% growth rate is unlikely to last.
Logan Eniac
Logan Eniac
30 Oct 2026
Transmetro Corporation (ASX:TCO) delivered a 50% increase in FY2026 net profit to A$4.49 million, while cash rose to A$13.94 million and the fully franked dividend increased to 6 cents per share. The debt-free hotel operator is preparing to open Metro Hotel Martin Place Sydney and support a major refurbishment of its 220-room Marlow property.
Victor Sage
Victor Sage
29 Oct 2026
Emyria has reported record quarterly revenue of approximately $1.42 million after opening its first Sydney Empax clinic and expanding national treatment capacity. The growth comes with $2.28 million in operating cash outflows and an estimated 2.08 quarters of funding at quarter-end.
Ada Torres
Ada Torres
29 Oct 2026
Iris Cairns Property has lifted its relevant interest in Reef Casino Trust to 96.50%, crossing the threshold needed to compulsorily acquire the remaining units at $4.67 each. The offer closes on 9 November and Iris says it will not be extended unless required by law.
Victor Sage
Victor Sage
28 Oct 2026
oOh!media shareholders will vote on I Squared Capital’s proposed acquisition on 2 November, with court approval scheduled two days later if the scheme passes. The filing sets the next milestones but does not change the transaction’s terms or guarantee completion.
Victor Sage
Victor Sage
28 Oct 2026
AusQuest’s Cangallo copper-gold discovery has been declared a Project of National Interest by the Peruvian Government, strengthening surface-rights protection and project security for the next four years. The designation arrives as the company prepares a 20-pad drilling campaign and seeks approval for another 20 pads in 2027.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Frasers Group has declared its A$0.65 per share cash offer for Accent Group best and final, removing the prospect of a higher bid from Frasers before the takeover closes. Accent shareholders now have until 29 January 2027 to decide whether immediate cash certainty outweighs the company’s standalone growth plans.
Logan Eniac
Logan Eniac
28 Oct 2026
OncoSil Medical delivered sharper commercial growth and a string of regulatory milestones in FY26, but the oncology device company remains heavily loss-making and dependent on future sales or fresh capital. Revenue rose 44% to $1.68 million while operating cash outflow reached $10.47 million.
Victor Sage
Victor Sage
27 Oct 2026

Browse the archive

Full archive